Cargando…
PIDD interaction with KEAP1 as a new mutation-independent mechanism to promote NRF2 stabilization and chemoresistance in NSCLC
Chemotherapy resistance is a major problem in non-small cell lung cancer (NSCLC) treatment. A major mechanism of chemoresistance involves stabilization of the NRF2 transcription factor. NRF2 levels are normally tightly regulated through interaction with KEAP1, an adaptor that targets NRF2 to the CUL...
Autores principales: | Ji, Lili, Zhang, Rui, Chen, Jie, Xue, Qun, Moghal, Nadeem, Tsao, Ming-Sound |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712044/ https://www.ncbi.nlm.nih.gov/pubmed/31455821 http://dx.doi.org/10.1038/s41598-019-48763-4 |
Ejemplares similares
-
The NRF2 antagonist ML385 inhibits PI3K‐mTOR signaling and growth of lung squamous cell carcinoma cells
por: Ji, Lili, et al.
Publicado: (2022) -
DDRGK1 Enhances Osteosarcoma Chemoresistance via Inhibiting KEAP1‐Mediated NRF2 Ubiquitination
por: Wang, Xin, et al.
Publicado: (2023) -
PIDD mediates and stabilizes the interaction between RAIDD and Caspase-2 for the PIDDosome assembly
por: Jang, Tae-ho, et al.
Publicado: (2013) -
ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer
por: Purohit, Vinee, et al.
Publicado: (2021) -
WDR23 regulates NRF2 independently of KEAP1
por: Lo, Jacqueline Y., et al.
Publicado: (2017)